Princeton, New Jersey, October 13, 2010 - Sandoz announced today the launch of pramipexole dihydrochloride tablets, a generic equivalent of Mirapex®, in the US. Pramipexole dihydrochloride tablets are ...

Pramipexole is a prescription drug. It comes in immediate-release and extended-release oral tablets. Pramipexole oral tablets are available as the brand-name drugs Mirapex and Mirapex ER. Pramipexole ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Zydus Pharmaceuticals, Inc., a wholly owned subsidiary of Cadila Healthcare has received the final approval from the USFDA to market pramipexole Dihydrochloride extended-release tablets in strengths ...

Pramipexole Dihydrochloride Tablets, 0.125 mg, 0.25 mg, 0.5 mg, 1 mg and 1.5 mg, the generic version of Boehringer Ingelheim's Mirapex® Tablets, a Parkinson's disease treatment. Pramipexole ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

NORTH WALES, Pa. A generic drug maker has announced the availability of a treatment of the signs and symptoms of idiopathic Parkinson’s disease. Pramipexole diHCl tablets are available in a 0.125-mg ...

Share price of Unichem Laboratories added 4.7 percent in the early trade on Monday after company received ANDA approval from USFDA. The company has received final ANDA approval for its Pramipexole ...

Betting big on Pramipexole Dihydrochloride, the generic version of Boehringer Ingelheim’s Mirapex tablets, Glenmark Generics Ltd, a unit of Glenmark Pharmaceuticals Ltd, is gearing up to take on ...